Evaluation of serum KL-6, a mucin-like glycoprotein, as a tumor marker for breast cancer

Clinical Cancer Research

Volumn 6, Issue 10, 2000, Pages 4069-4072

  Ogawa, Y ^a   Ishikawa, T ^a   Ikeda, K ^a   Nakata, B ^a   Sawada, T ^a   Ogisawa, K ^a   Kato, Y ^a   Hirakawa, K ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE ANTIGEN; CARCINOEMBRYONIC ANTIGEN; GLYCOPROTEIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER STATISTICS; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANTIGENS; ANTIGENS, NEOPLASM; BREAST DISEASES; BREAST NEOPLASMS; CA-15-3 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOENZYME TECHNIQUES; MIDDLE AGED; MUCINS; PEPTIDE FRAGMENTS; PROCOLLAGEN; RECURRENCE; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 0033755179     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Serum marker combinations in human breast cancer
2. Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer
3. Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma
4. Third international workshop on lung tumor and differentiation antigens: Overview of the results of the central data analysis
5. Comparative evaluation of sialylated carbohydrate antigens, KL-6, CA19-9, and SLX as serum markers for interstitial pneumonia
6. KL-6, a human MUC-1 mucin, is chemotactic for human fibroblasts
7. New serum indicator of interstitial pneumonitis activity: Sialylated carbohydrate antigen KL-6
8. Prognostic value of histologic grade nuclear components of Scarff-Bloom-Richardson (SBR)
9. Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer
10. The value of MCA, CA 15-3, CEA and CA 125 for discrimination between metastatic breast cancer and adenocarcinoma of other primary types
11. The contribution of ultrasonography to the differential diagnosis of breast cancer
12. Prognostic indicators in invasive breast cancer
13. Overview of the biologic markers of breast cancer
14. Perspectives on the feature of cancer markers
15. Prediction of disease relapse in patients with breast cancer: Evaluation of prognostic factors and contribution of risk scores